Prognostic value of circulating CD34+ cells in myelodysplastic syndromes

Clara Cesana, Catherine Klersy, Bruno Brando, Annamaria Nosari, Barbara Scarpati, Linda Scampini, Alfredo Molteni, Guido Nador, Luca Santoleri, Marta Formenti, Marina Valentini, Antonino Mazzone, Enrica Morra, Roberto Cairoli

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

We studied circulating (C)CD34+ cells by flow cytometry in 96 patients with myelodisplastic syndromes (MDS) at diagnosis, and in a subset of 35 cases during follow-up. CCD34+ counts were stratified within both International Prognostic Scoring System (IPSS) and World Health Organization (WHO) categories. Counts >10/μl were associated with poorer leukemia-free survival, a prognostic value for evolution independent from that of WHO, and a higher progression probability within intermediate-risk IPSS and WHO classes. When serial measurements were performed, counts >10/μl more frequently correlated to evolution. Separating newly diagnosed patients on the basis of 10/μl cut-off of circulating CD34+ cells retains prognostic utility, especially in intermediate-risk MDS.

Original languageEnglish
Pages (from-to)1715-1723
Number of pages9
JournalLeukemia Research
Volume32
Issue number11
DOIs
Publication statusPublished - Nov 2008

Fingerprint

Myelodysplastic Syndromes
Flow Cytometry
Leukemia
Survival

Keywords

  • Circulating CD34 cells
  • Flow cytometry
  • International Prognostic Scoring System
  • Myelodysplastic syndrome
  • Peripheral blood
  • Prognosis
  • WHO

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Cesana, C., Klersy, C., Brando, B., Nosari, A., Scarpati, B., Scampini, L., ... Cairoli, R. (2008). Prognostic value of circulating CD34+ cells in myelodysplastic syndromes. Leukemia Research, 32(11), 1715-1723. https://doi.org/10.1016/j.leukres.2008.03.028

Prognostic value of circulating CD34+ cells in myelodysplastic syndromes. / Cesana, Clara; Klersy, Catherine; Brando, Bruno; Nosari, Annamaria; Scarpati, Barbara; Scampini, Linda; Molteni, Alfredo; Nador, Guido; Santoleri, Luca; Formenti, Marta; Valentini, Marina; Mazzone, Antonino; Morra, Enrica; Cairoli, Roberto.

In: Leukemia Research, Vol. 32, No. 11, 11.2008, p. 1715-1723.

Research output: Contribution to journalArticle

Cesana, C, Klersy, C, Brando, B, Nosari, A, Scarpati, B, Scampini, L, Molteni, A, Nador, G, Santoleri, L, Formenti, M, Valentini, M, Mazzone, A, Morra, E & Cairoli, R 2008, 'Prognostic value of circulating CD34+ cells in myelodysplastic syndromes', Leukemia Research, vol. 32, no. 11, pp. 1715-1723. https://doi.org/10.1016/j.leukres.2008.03.028
Cesana, Clara ; Klersy, Catherine ; Brando, Bruno ; Nosari, Annamaria ; Scarpati, Barbara ; Scampini, Linda ; Molteni, Alfredo ; Nador, Guido ; Santoleri, Luca ; Formenti, Marta ; Valentini, Marina ; Mazzone, Antonino ; Morra, Enrica ; Cairoli, Roberto. / Prognostic value of circulating CD34+ cells in myelodysplastic syndromes. In: Leukemia Research. 2008 ; Vol. 32, No. 11. pp. 1715-1723.
@article{f37609e2d0764b9f8423aaf0f31f5cad,
title = "Prognostic value of circulating CD34+ cells in myelodysplastic syndromes",
abstract = "We studied circulating (C)CD34+ cells by flow cytometry in 96 patients with myelodisplastic syndromes (MDS) at diagnosis, and in a subset of 35 cases during follow-up. CCD34+ counts were stratified within both International Prognostic Scoring System (IPSS) and World Health Organization (WHO) categories. Counts >10/μl were associated with poorer leukemia-free survival, a prognostic value for evolution independent from that of WHO, and a higher progression probability within intermediate-risk IPSS and WHO classes. When serial measurements were performed, counts >10/μl more frequently correlated to evolution. Separating newly diagnosed patients on the basis of 10/μl cut-off of circulating CD34+ cells retains prognostic utility, especially in intermediate-risk MDS.",
keywords = "Circulating CD34 cells, Flow cytometry, International Prognostic Scoring System, Myelodysplastic syndrome, Peripheral blood, Prognosis, WHO",
author = "Clara Cesana and Catherine Klersy and Bruno Brando and Annamaria Nosari and Barbara Scarpati and Linda Scampini and Alfredo Molteni and Guido Nador and Luca Santoleri and Marta Formenti and Marina Valentini and Antonino Mazzone and Enrica Morra and Roberto Cairoli",
year = "2008",
month = "11",
doi = "10.1016/j.leukres.2008.03.028",
language = "English",
volume = "32",
pages = "1715--1723",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Ltd",
number = "11",

}

TY - JOUR

T1 - Prognostic value of circulating CD34+ cells in myelodysplastic syndromes

AU - Cesana, Clara

AU - Klersy, Catherine

AU - Brando, Bruno

AU - Nosari, Annamaria

AU - Scarpati, Barbara

AU - Scampini, Linda

AU - Molteni, Alfredo

AU - Nador, Guido

AU - Santoleri, Luca

AU - Formenti, Marta

AU - Valentini, Marina

AU - Mazzone, Antonino

AU - Morra, Enrica

AU - Cairoli, Roberto

PY - 2008/11

Y1 - 2008/11

N2 - We studied circulating (C)CD34+ cells by flow cytometry in 96 patients with myelodisplastic syndromes (MDS) at diagnosis, and in a subset of 35 cases during follow-up. CCD34+ counts were stratified within both International Prognostic Scoring System (IPSS) and World Health Organization (WHO) categories. Counts >10/μl were associated with poorer leukemia-free survival, a prognostic value for evolution independent from that of WHO, and a higher progression probability within intermediate-risk IPSS and WHO classes. When serial measurements were performed, counts >10/μl more frequently correlated to evolution. Separating newly diagnosed patients on the basis of 10/μl cut-off of circulating CD34+ cells retains prognostic utility, especially in intermediate-risk MDS.

AB - We studied circulating (C)CD34+ cells by flow cytometry in 96 patients with myelodisplastic syndromes (MDS) at diagnosis, and in a subset of 35 cases during follow-up. CCD34+ counts were stratified within both International Prognostic Scoring System (IPSS) and World Health Organization (WHO) categories. Counts >10/μl were associated with poorer leukemia-free survival, a prognostic value for evolution independent from that of WHO, and a higher progression probability within intermediate-risk IPSS and WHO classes. When serial measurements were performed, counts >10/μl more frequently correlated to evolution. Separating newly diagnosed patients on the basis of 10/μl cut-off of circulating CD34+ cells retains prognostic utility, especially in intermediate-risk MDS.

KW - Circulating CD34 cells

KW - Flow cytometry

KW - International Prognostic Scoring System

KW - Myelodysplastic syndrome

KW - Peripheral blood

KW - Prognosis

KW - WHO

UR - http://www.scopus.com/inward/record.url?scp=47249137774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47249137774&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2008.03.028

DO - 10.1016/j.leukres.2008.03.028

M3 - Article

C2 - 18456323

AN - SCOPUS:47249137774

VL - 32

SP - 1715

EP - 1723

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 11

ER -